Related Experiment Video
Updated: May 8, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
TOSO promotes β-cell proliferation and protects from apoptosis
G Dharmadhikari1, M Mühle, F T Schulthess
1Centre for Biomolecular Interactions Bremen, University of Bremen, Germany.
Abstract:
Decreased β-cell mass reflects a shift from quiescence/proliferation into apoptosis, it plays a crucial role in the pathophysiology of diabetes. A major attempt to restore β-cell mass and normoglycemia is to improve β-cell survival. Here we show that switching off the Fas pathway using Fas apoptotic inhibitory protein (Faim/TOSO), which regulates apoptosis upstream of caspase 8, blocked β-cell apoptosis and increased proliferation in human islets. TOSO was clearly expressed in pancreatic β-cells and down-regulated in T2DM. TOSO expression correlated with β-cell turnover; at conditions of improved survival, TOSO was induced. In contrast, TOSO downregulation induced β-cell apoptosis. Although TOSO overexpression resulted in a 3-fold induction of proliferation, proliferating β-cells showed a very limited capacity to undergo multiple rounds of replication. Our data suggest that TOSO is an important regulator of β-cell turnover and switches β-cell apoptosis into proliferation.
Insights
Fas apoptotic inhibitory protein (TOSO) blocks pancreatic beta-cell death and promotes proliferation, offering a potential therapeutic target for diabetes by regulating beta-cell survival and turnover.
Area of Science:
- Endocrinology
- Cell Biology
- Diabetes Research
Background:
- Decreased beta-cell mass is central to diabetes pathophysiology, driven by increased apoptosis.
- Restoring beta-cell mass and function is a key therapeutic goal for managing diabetes.
Purpose of the Study:
- To investigate the role of Fas apoptotic inhibitory protein (Faim/TOSO) in regulating beta-cell apoptosis and proliferation.
- To explore TOSO as a potential therapeutic target for diabetes.
Main Methods:
- Investigated the effect of modulating the Fas pathway using Faim/TOSO in human islets.
- Assessed beta-cell apoptosis, proliferation, and TOSO expression in relation to Type 2 Diabetes Mellitus (T2DM).
Main Results:
- Inhibition of the Fas pathway via Faim/TOSO blocked beta-cell apoptosis and enhanced proliferation in human islets.
- TOSO expression was detected in pancreatic beta-cells and found to be downregulated in T2DM.
- TOSO expression correlated with beta-cell turnover, with induction under conditions of improved survival and downregulation leading to apoptosis.
Conclusions:
- Faim/TOSO acts as a crucial regulator of beta-cell turnover, shifting the balance from apoptosis towards proliferation.
- TOSO represents a promising target for therapeutic strategies aimed at preserving beta-cell mass in diabetes.
More Related Videos
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Related Concept Videos
TGF - β Signaling Pathway
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology
Insulin: The Receptor and Signaling Pathways
Type II Diabetes II: Pathophysiology
Insulin Secretory Vesicles